@article{TLCR23046,
author = {Alfredo Addeo and Giuseppe Luigi Banna},
title = {PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 3},
year = {2018},
keywords = {},
abstract = {Immune checkpoint inhibitors (ICPIs) targeting the programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) axis have dramatically expanded the therapeutic armamentarium for non-small cell lung cancer (NSCLC) and are now standard treatments for patients with advanced disease (1).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/23046}
}